{
    "relation": [
        [
            "Valuation",
            "Price/Earnings",
            "Price/Sales",
            "Price/Book",
            "Price/Cash Flow",
            "TEV/Sales"
        ],
        [
            "BABY",
            "40.8x",
            "4.0x",
            "3.9x",
            "39.1x",
            "3.9x"
        ],
        [
            "Industry Range",
            "",
            "",
            "",
            "",
            ""
        ]
    ],
    "pageTitle": "NATUS MEDICAL INC (BABY:NASDAQ GS): Stock Quote & Company Profile - Businessweek",
    "title": "",
    "url": "http://www.bloomberg.com/research/stocks/snapshot/snapshot.asp?ticker=BABY",
    "hasHeader": true,
    "headerPosition": "FIRST_ROW",
    "tableType": "RELATION",
    "tableNum": 3,
    "s3Link": "common-crawl/crawl-data/CC-MAIN-2015-32/segments/1438042988399.65/warc/CC-MAIN-20150728002308-00336-ip-10-236-191-2.ec2.internal.warc.gz",
    "recordEndOffset": 329401631,
    "recordOffset": 329371587,
    "tableOrientation": "HORIZONTAL",
    "TableContextTimeStampBeforeTable": "{36853=+65 6212 1000, 37185=+1 212 318 2000}",
    "TableContextTimeStampAfterTable": "{13336=Natus Medical Incorporated announced unaudited and consolidated financial results for the second quarter and six months ended June 30, 2015. For the second quarter, the company reported revenue of $91,937,000 against $86,325,000 reported for the second quarter of 2014. Income from operations was $14,002,000 against $9,945,000 a year ago. Income before tax was $13,622,000 against $10,740,000 a year ago. Net income was $9,851,000 or $0.30 diluted earnings per share against $7,461,000 or $0.23 diluted earnings per share a year ago. Non-GAAP income before provision for income tax was $16,640,000 against $12,264,000 for the same period in the last year. Non-GAAP net income was $11,158,000 or $0.34 diluted earnings per share against $8,928,000 or $0.28 diluted earnings per share for the same period in the last year. Non-GAAP Operating profit $17,020,000 against $11,469,000 for the same period in the last year. For six months, the company reported revenue of $181,332,000 against $171,948,000 reported for the second quarter of 2014. Income from operations was $27,348,000 against $19,332,000 a year ago. Income before tax was $26,138,000 against $20,439,000 a year ago. Net income was $18,447,000 or $0.56 diluted earnings per share against $14,216,000 or $0.44 diluted earnings per share a year ago. Non-GAAP income before provision for income tax was $30,949,000 against $24,269,000 for the same period in the last year. Non-GAAP net income was $21,431,000 or $0.65 diluted earnings per share against $17,219,000 or $0.53 diluted earnings per share for the same period in the last year. Non-GAAP Operating profit $32,159,000 against $23,162,000 for the same period in the last year. The company provided revenue and earnings guidance for the third quarter and increased its earnings guidance for the full year 2015. For the third quarter of 2015, the company expects revenue of $93.0 million to $94.0 million and non-GAAP earnings per share of $0.37 to $0.38. The company increased its non-GAAP earnings guidance for the full year 2015 and expects to report non-GAAP earnings per share of $1.50 to $1.52, an increase from previous guidance of $1.47 to $1.51. Full year 2015 revenue guidance was unchanged at $376 million to $378 million., 4814=Natus Medical Incorporated designs, manufactures, and markets newborn care and neurology healthcare products and services worldwide. It offers healthcare products and services used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and balance and mobility disorders. The company\u2019s product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology; and software systems for managing and tracking disorders and diseases for public health laboratories. Its neurology products comprise diagnostic electroencephalography and long-term monitoring products, electrodiagnostic monitoring products, diagnostic polysomnography monitoring products, diagnostic intraoperative monitoring products, and transcranial Doppler products. The company\u2019s newborn care products include hearing screening products to screen the hearing in the newborn; brain injury products to diagnose the severity of brain injury, monitor the effectiveness of drug therapies, detect seizure activity and monitor general neurological status; and thermoregulation products to control the newborn environment, including incubators and warmers. Its newborn care products also comprise jaundice management products to measure bilirubin levels and treat jaundice; diagnostic hearing assessment products to screen for or diagnose hearing loss, or to identify abnormalities affecting the peripheral and central auditory nervous systems in patients of all ages; and balance and mobility systems to diagnose and assist in treating balance disorders. The company serves hospitals, clinics, laboratories, physicians, nurses, audiologists, and governmental agencies. Natus Medical Incorporated was founded in 1987 and is headquartered in Pleasanton, California., 15926=Natus Medical Inc. announced that they will report Q2, 2015 results at 9:00 AM, Eastern Standard Time on Jul 22, 2015, 16380=Natus Medical Inc., Q2 2015 Earnings Call, Jul 22, 2015}",
    "textBeforeTable": "Industry Average BABY Industry Analysis \u00a0 // ]]> } document.write(BW_adsys('Right3')); if (window.BW_adsys) { // <script type=\"text/javascript\"> <div class=\"\" style=\"width:300px; margin: auto; \"> <div class=\"ad\"> </div> </table> </tbody> </tr> <td class=\"noDataRR\" style=\"border:none;\" colspan=\"3\"><a class=\"link_xs\" href=\"../../sectorandindustry/industries/industrydetail.asp?code=351010\">View Industry Companies</a></td> <tr> </tr> <td align=\"right\"><span class=\"posData\">+1.00</span></td> <td align=\"right\">916.00 <span class=\"xSmGreyTxt\">GBp</span></td> <td><a class=\"link_xsb\" href=\"../snapshot/snapshot.asp?ticker=OXIG:LN\">Oxford Instruments PLC</a></td> <tr> </tr> <td align=\"right\"><span class=\"negData\">-0.0281</span></td> <td align=\"right\">$0.80 <span class=\"xSmGreyTxt\">USD</span></td> <td><a class=\"link_xsb\" href=\"../snapshot/snapshot.asp?ticker=NURO:US\">NeuroMetrix Inc</a></td> <tr> <tbody> </thead> </tr> <td width=\"50\" align=\"right\">Change</td> <td width=\"75\" align=\"right\">Last</td> <td>Company</td> <tr> <thead> <table class=\"colRight\" width=\"100%\" cellpadding=\"0\" cellspacing=\"0\"> <div class=\"clear\"></div> </div> <p class=\"note fLeft\" style=\"width:64%; text-align: right; padding: 5px 0; border-top: 3px solid #6B7B84; margin-top: 20px;\">Market data is delayed at least 15 minutes.</p> <h2 class=\"sectionTitle fLeft\" style=\"width: 35%; border-bottom: 0;\">BABY Competitors</h2> <div style=\"border-bottom: 1px solid #ccc; overflow: hidden;\"> <div class=\"\"> </div> </table> </tbody> </tr> <td width=\"75\" align=\"right\" class=\"noBorder\"><img src=\"/cgi-bin/upload.dll/file.png?z07ae100az4a63814f3e4f451482fd7cffd8018cad\" width=\"60\" height=\"15\" galleryimg=\"no\" symbol=\"US;BABY\" /></td> <td align=\"right\" width=\"45\" class=\"noBorder\"><span class=\"negData\">-0.19</span></td> <td align=\"right\" class=\"noBorder\">$45.16 <span class=\"xSmGreyTxt\">USD</span></td> <td scope=\"row\"> <a class=\"link_xsb\" style=\"text-align:left\" target=\"_top\" href=\"../../stocks/snapshot/snapshot.asp?ticker=BABY\"> BABY:US </a> </td> <tr class=\"lastRow\"> <tbody> </thead> </tr> <td colspan=\"4\">Recently Viewed</td> <tr> <thead> <table class=\"miniTable\" summary=\"Recently viewed\"> </form> </fieldset> <a style=\"font-size:11px;\" target=\"_top\" href=\"../../common/symbollookup/symbollookup.asp\">Company Lookup</a> <input type=\"image\" name=\"submit\" src=\"http://images.businessweek.com/gen/buttons/stock_go_btn.gif\" align=\"absmiddle\" /> <input type=\"text\" id=\"lookupSymbol\" class=\"symbol\" autocomplete=\"off\"",
    "textAfterTable": "View Detailed BABY Financials \u00a0|\u00a0 View Sector Analysis Sponsored Financial Commentaries Sponsored Links Browse Companies A B C D E F G H I J K L M N O P Q R S T U V W X Y Z \u00a0|\u00a0 0 1 2 3 4 5 6 7 8 9 Report Data Issue To contact NATUS MEDICAL INC, please visit www.natus.com. Company data is provided by Capital IQ. Please use this form to report any data issues. Information Missing - Please enter your information in the following field(s): Company Name Your Name* Your E-Mail Address*",
    "hasKeyColumn": true,
    "keyColumnIndex": 0,
    "headerRowIndex": 0
}